Checkpoint Blockade Therapy Clears Safety Hurdle for Patients With HIV and Cancer
Although there has been reluctance among oncology researchers to administer immunotherapy to patients with HIV who develop cancer, early signals from a small clinical trial suggest that such a strategy may be safe in certain settings.
Source: OncLive